Navigation Links
DMG is Proud to Announce that CD Diagnostics will be Featured in an Upcoming Episode of Health Heroes

Wynnewood, PA (PRWEB) March 15, 2013

CD Diagnostics announced today that they will be featured in an upcoming episode of Health Heroes.

Located in Wynnewood, PA, CD Diagnostics is a leader in joint fluid analysis. The company’s scientific founder, Carl Deirmengian, MD, discovered the existence of unique genetic signatures for joint disease and infection, as indicated by the presence of various biomarkers in synovial (joint) fluid. By identifying and measuring these unique biomarkers, CD Diagnostics is able to develop a series of new products to diagnose joint disease with greater accuracy and speed than other tests currently available. The company’s first joint infection test, marketed as Synovasure™, was released as a laboratory developed test in November 2012 and continues to receive tremendous positive feedback from the orthopaedic community. A point of care device that will diagnose joint infection at the bedside is currently being developed, and the company plans to release this test in Europe later this year.

Matt Monaghan, Global Vice President of Zimmer Hips, commented that, "The early detection and treatment of infection is critical to successful clinical outcomes. We believe Synovasure™ will enable surgeons to quickly and accurately identify patients presenting with infection through a simple, streamlined process."

This particular episode of Health Heroes will educate our viewers about the impact of CD Diagnostics' game changing technology for the orthopaedic community. The company’s pipeline of tests will be the first simple, standardized, analytical devices available for joint fluid analysis. The Health Heroes feature will explain CD Diagnostics’ biomarker screening program, patented technology, and its core strengths in immunoassay development and manufacturing. Through the combination of its CLIA laboratory, Citrano Medical Laboratories, and its strength in immunoassay development, CD Diagnostics is able to develop diagnostic tests for a broad range of joint diseases including infection, rheumatoid arthritis, osteoarthritis, and companion diagnostics in a simple, rapid, and accurate format.

Testing services for Synovasure™ LDT, the company’s joint infection test, are provided through CD Diagnostics’ CLIA lab in Towson, Maryland. Results are turned around to physicians within 24hrs.

Richard Birkmeyer, CEO of CD Diagnostics stated, “We are very excited about our feature on Health Heroes. We believe that our breakthrough technology will have a tremendous impact on the orthopaedic community and are pleased to shed light on joint infection, a serious condition that negatively affects joint replacement patients worldwide.”

“When discussing technology, the true marvels today are happening behind closed doors,” said Michele Nehls, producer for the Health Heroes series. “I’m proud to be able to bring an inside perspective to the Health Heroes audience.”

About CD Diagnostics:
CD Diagnostics is a leader in joint fluid analysis focused on developing novel diagnostic tests for joint disease. The Company aims to improve patient outcomes through innovative technologies that provide more accurate and rapid diagnosis for joint pain and infection. As part of its commitment to joint fluid research, CD Diagnostics is creating a repository of joint fluid samples from a global network of physicians to facilitate biomarker screening services for synovial and spinal fluids. Combining biomarker identification with patented technology and expertise in immunoassay development and manufacturing, CD Diagnostics is developing a range of products that address challenging diagnostic determinations in joint health and therapeutic outcomes.

For more information, visit: or call (484) 476-4800.

About Health Heroes:
Health Heroes is a powerful TV series dedicated to defining and exploring today’s latest medical advances in all areas of health and wellness. Written with both the industry professional and television audience in mind, Health Heroes educates, entertains and enlightens the lives of our viewers.

For more information visit: or call (866) 496-4065.

Media Contact:
Michele Nehls, Executive Producer - Health Heroes
DMG Productions
(866) 496-4065 x 822

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Health Heroes and DMG Productions Proudly Announce Airing of New Episodes
2. Waterfront Properties Proud To Have Prestigious Max Planck Society in its Back Yard
3. The Scientist Proudly Announces the Top 10 Innovations of 2012
4. Aveka Nutra Processing proudly begins producing products from Z Trim Holdings, Inc.
5. Verenium Announces Preliminary Financial Results For Fiscal 2012
6. Probiotic Action Announces Probiotics Lead the Digestive Health Market
7. Annual Conference about Technology Solutions for People with Disabilities Announces Program
8. DistinctBright, Probiotic Cleaner, Announces their Probiotic Cleaner is Safe for Pets
9. Research and Markets Announces the Release of Transdermal Pain Management to 2016. Products, Markets, Forecasts and Opportunities
10. Z Trim Holdings Announces Conclusion of Successful Warrant Exercise Program: Raises $2.195 Million
11. EAG Announces General Manager of Environmental Fate, Chemistry and Ecotoxicology (EFCE) Division
Post Your Comments:
(Date:11/30/2015)...  Champions Oncology, Inc. (CSBR), engaged in the development ... development and use of oncology drugs, today announced that ... presenting at the LD MICRO Investor Conference on Wednesday, ... The conference, held at the Luxe Sunset Bel Air ... will feature 200 small/micro-cap companies and is expected to ...
(Date:11/30/2015)... Ill. , Nov. 30, 2015  AbbVie, is ... program that focuses on a daily routine for managing ... take their medication can affect the way the body ... follow to their a daily routine are important. The ... to help patients better manage their hypothyroidism by establishing ...
(Date:11/28/2015)... ... 2015 , ... • Jeon Jin Bio Corp, a Korean Biotech venture company, ... , Bird Free, an oil-based, gel formula made ... including visual, smell, taste and touch, enabling safe, effective avian control without toxic chemicals ...
(Date:11/26/2015)... , November 26, 2015 --> ... company specializing in imaging technologies, announced today that it has ... part of the Horizon 2020 European Union Framework Programme for ... large-scale clinical trial in breast cancer. , ... --> --> The study ...
Breaking Biology Technology:
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
(Date:10/29/2015)... 29, 2015  Rubicon Genomics, Inc., today announced ... of its DNA library preparation products, including the ... ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has been optimized ... NGS libraries for liquid biopsies--the analysis of cell-free ... applications in cancer and other conditions. Eurofins Scientific ...
(Date:10/27/2015)... -- Munich, Germany , October ... automatically maps data from mobile eye tracking videos created ... that they can be quantitatively analyzed with SMI,s analysis ... , October 28-29, 2015. SMI,s Automated Semantic Gaze ... tracking videos created with SMI,s Eye Tracking Glasses ...
Breaking Biology News(10 mins):